Ghariani Inès, Braham Néjia Jmili, Bekir Leila
Laboratoire de biologie clinique (Unité d'hématologie), CHU Mongi Slim de la Marsa, 2046 Tunisie, Faculté de Pharmacie de Monastir, 5000 Tunisie.
Faculté de Pharmacie de Monastir, 5000 Tunisie, Service d'hématologie, CHU Farhat Hached, Sousse 4031, Tunisie.
Ann Biol Clin (Paris). 2023 Mar 15;81(1):91-95. doi: 10.1684/abc.2023.1787.
Evans syndrome (ES) is a rare and chronic autoimmune disease characterized by the concomitant or sequential association of auto-immune hemolytic anemia (AIHA) with immune thrombocytopenia (ITP), and less frequently autoimmune neutropenia. Coronavirus disease 2019 (Covid-19) may cause various hematologic conditions. COVID-19 may also induce Evans syndrome via immune mechanisms. Here, we describe the case of a patient developing Evans syndrome as initial presentation of Covid-19 infection.
伊文氏综合征（ES）是一种罕见的慢性自身免疫性疾病，其特征为自身免疫性溶血性贫血（AIHA）与免疫性血小板减少症（ITP）同时或相继出现，较少见的情况是伴有自身免疫性中性粒细胞减少症。2019冠状病毒病（Covid-19）可能导致各种血液系统疾病。Covid-19也可能通过免疫机制诱发伊文氏综合征。在此，我们描述了一例以伊文氏综合征为Covid-19感染首发表现的患者病例。
